Viewing Study NCT05007951


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2025-12-31 @ 3:23 PM
Study NCT ID: NCT05007951
Status: COMPLETED
Last Update Posted: 2024-04-08
First Post: 2021-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)
Sponsor: SK Bioscience Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module